263 related articles for article (PubMed ID: 35579170)
1. Poloxamer-188 Exacerbates Brain Amyloidosis, Presynaptic Dystrophies, and Pathogenic Microglial Activation in 5XFAD Mice.
Di Meco A; Kemal S; Popovic J; Chandra S; Sadleir K; Vassar R
Curr Alzheimer Res; 2022; 19(4):317-329. PubMed ID: 35579170
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
[TBL] [Abstract][Full Text] [Related]
3. Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice.
Cuddy LK; Alia AO; Salvo MA; Chandra S; Grammatopoulos TN; Justman CJ; Lansbury PT; Mazzulli JR; Vassar R
Mol Neurodegener; 2022 Aug; 17(1):54. PubMed ID: 35987691
[TBL] [Abstract][Full Text] [Related]
4. Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.
Bosch ME; Dodiya HB; Michalkiewicz J; Lee C; Shaik SM; Weigle IQ; Zhang C; Osborn J; Nambiar A; Patel P; Parhizkar S; Zhang X; Laury ML; Mondal P; Gomm A; Schipma MJ; Mallah D; Butovsky O; Chang EB; Tanzi RE; Gilbert JA; Holtzman DM; Sisodia SS
Mol Neurodegener; 2024 Feb; 19(1):18. PubMed ID: 38365827
[TBL] [Abstract][Full Text] [Related]
5. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease.
Andrew RJ; Fernandez CG; Stanley M; Jiang H; Nguyen P; Rice RC; Buggia-Prévot V; De Rossi P; Vetrivel KS; Lamb R; Argemi A; Allaert ES; Rathbun EM; Krause SV; Wagner SL; Parent AT; Holtzman DM; Thinakaran G
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9665-E9674. PubMed ID: 29078331
[TBL] [Abstract][Full Text] [Related]
6. L-type calcium channel antagonist isradipine age-dependently decreases plaque associated dystrophic neurites in 5XFAD mouse model.
Wickline JL; Smith S; Shin R; Odfalk K; Sanchez J; Javors M; Ginsburg B; Hopp SC
Neuropharmacology; 2023 Apr; 227():109454. PubMed ID: 36740015
[TBL] [Abstract][Full Text] [Related]
7. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.
Xia D; Lianoglou S; Sandmann T; Calvert M; Suh JH; Thomsen E; Dugas J; Pizzo ME; DeVos SL; Earr TK; Lin CC; Davis S; Ha C; Leung AW; Nguyen H; Chau R; Yulyaningsih E; Lopez I; Solanoy H; Masoud ST; Liang CC; Lin K; Astarita G; Khoury N; Zuchero JY; Thorne RG; Shen K; Miller S; Palop JJ; Garceau D; Sasner M; Whitesell JD; Harris JA; Hummel S; Gnörich J; Wind K; Kunze L; Zatcepin A; Brendel M; Willem M; Haass C; Barnett D; Zimmer TS; Orr AG; Scearce-Levie K; Lewcock JW; Di Paolo G; Sanchez PE
Mol Neurodegener; 2022 Jun; 17(1):41. PubMed ID: 35690868
[TBL] [Abstract][Full Text] [Related]
8. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
9. CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease.
Puntambekar SS; Moutinho M; Lin PB; Jadhav V; Tumbleson-Brink D; Balaji A; Benito MA; Xu G; Oblak A; Lasagna-Reeves CA; Landreth GE; Lamb BT
Mol Neurodegener; 2022 Jun; 17(1):47. PubMed ID: 35764973
[TBL] [Abstract][Full Text] [Related]
10. Most dystrophic neurites in the common 5xFAD Alzheimer mouse model originate from axon terminals.
Mabrouk R; Miettinen PO; Tanila H
Neurobiol Dis; 2023 Jun; 182():106150. PubMed ID: 37172911
[TBL] [Abstract][Full Text] [Related]
11. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice.
Wegiel J; Wang KC; Imaki H; Rubenstein R; Wronska A; Osuchowski M; Lipinski WJ; Walker LC; LeVine H
Neurobiol Aging; 2001; 22(1):49-61. PubMed ID: 11164276
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous imaging of redox states in dystrophic neurites and microglia at Aβ plaques indicate lysosome accumulation not microglia correlate with increased oxidative stress.
Wendt S; Johnson S; Weilinger NL; Groten C; Sorrentino S; Frew J; Yang L; Choi HB; Nygaard HB; MacVicar BA
Redox Biol; 2022 Oct; 56():102448. PubMed ID: 36037587
[TBL] [Abstract][Full Text] [Related]
13. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology.
Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL
Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991
[TBL] [Abstract][Full Text] [Related]
14. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
Shi Q; Chang C; Saliba A; Bhat MA
J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
[TBL] [Abstract][Full Text] [Related]
15. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R
PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504
[TBL] [Abstract][Full Text] [Related]
16. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
[TBL] [Abstract][Full Text] [Related]
18. An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation.
Cai Y; Xue ZQ; Zhang XM; Li MB; Wang H; Luo XG; Cai H; Yan XX
Neuroscience; 2012 Jul; 215():160-73. PubMed ID: 22542680
[TBL] [Abstract][Full Text] [Related]
19. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
[No Abstract] [Full Text] [Related]
20. Beneficial Effect of ACI-24 Vaccination on Aβ Plaque Pathology and Microglial Phenotypes in an Amyloidosis Mouse Model.
Rudan Njavro J; Vukicevic M; Fiorini E; Dinkel L; Müller SA; Berghofer A; Bordier C; Kozlov S; Halle A; Buschmann K; Capell A; Giudici C; Willem M; Feederle R; Lichtenthaler SF; Babolin C; Montanari P; Pfeifer A; Kosco-Vilbois M; Tahirovic S
Cells; 2022 Dec; 12(1):. PubMed ID: 36611872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
